Springworks Therapeutics earnings were -$301.1M for the trailing 12 months ending Jun 30, 2024, with N/A growth year over year. The latest SWTX earnings report on Jun 30, 2024 announced Q2 2024 earnings of -$39.9M, down 54.3% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, SWTX reported annual earnings of -$325.1M, with 17.2% growth. The next SWTX earnings date is Oct 31, 2024.
Springworks Therapeutics Earnings Reports & History FAQ
What were Springworks Therapeutics's earnings last quarter?
On SWTX's earnings call on Invalid Date, Springworks Therapeutics (NASDAQ: SWTX) reported Q2 2024 earnings per share (EPS) of -$0.54, up 56.8% year over year. Total SWTX earnings for the quarter were -$39.92 million. In the same quarter last year, Springworks Therapeutics's earnings per share (EPS) was -$1.25.
When does Springworks Therapeutics report earnings?
The next SWTX earnings date is Invalid Date. Add SWTX to your watchlist to be reminded of Springworks Therapeutics's next earnings date.
What was SWTX's earnings growth in the past year?
As of Springworks Therapeutics's earnings date in Invalid Date, Springworks Therapeutics's earnings has grown year over year. SWTX earnings in the past year totalled -$301.06 million.
Is Springworks Therapeutics profitable or losing money?
As of the last Springworks Therapeutics earnings report, Springworks Therapeutics is currently losing money. Springworks Therapeutics's net profit (also called net income) for the twelve months ending Jun 30, 2024 was -$301.06 million, a 1.06% increase year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.